Is BGM Group Ltd. (BGM) a Buy, Sell, or Hold?
BGM Group Ltd.
NASDAQ:BGM
$0.3122 USD
-$0.03 (-7.66%)
- Volume
- 119.43K
- Average Volume
- 456.3K
- Market Capitalization
- $62.63M
- P/E Ratio
- -1.56
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $11.80
- Year Low
- $0.26
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.39
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Chen Xin |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Current Symbol | BGM |
| CUSIP | G7307E123 |
| CIK | 0001779578 |
| Web | https://www.bgmgroupltd.com |
| Phone | 86 28 6477 5180 |
| Currency | USD |
| Employees | 298 |
| Country | CN |
Liquidity
| Debt-to-Equity Ratio | 0.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 3.39 |
| Quick Ratio | 2.82 |
| Cash Ratio | 1.12 |
Sales & Book Value
| Annual Sales | $25.1M |
| Price / Sales | 2.50 |
| Cash Flow | -0.47 |
| Price / Cash Flow | -18.49 |
| Price / Book | 0.05 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | N/A |
| Rating Score(0-5) | 0 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.2 |
| Trailing P/E Ratio | -1.56 |
| PEG Ratio | -0.02 |
| P/E Growth | -0.02 |
| Net Income | $-1.44M |
| Net Margin | -5.75% |
| Pretax Margin | -8.52% |
| Return on Equity | -3.37% |
| Return on Assets | -2.72% |
Financials Score
| AltmanZ Score | |
| Piotroski Score | |
| Working Capital | - |
| Total Assets | - |
| Ebit | - |
| Market Cap | - |
| Total Liabilities | - |
Poll Results
About BGM Group Ltd. (NASDAQ:BGM) Stock
Operating from Chengdu, People's Republic of China, BGM Group Ltd. engages in the manufacturing and supply of active pharmaceutical ingredients (APIs), traditional Chinese medicine (TCM) derivatives, and various other related products across China. The company's pharmaceutical portfolio includes an array of licorice-based items: Gan Di Xin, an oral medication for cough and expectorant relief; Qilian Shan Licorice Extract, serving as a raw material for pharmaceutical firms to produce conventional licorice tablets; and Qilian Shan licorice liquid extract, a key ingredient utilized by medical preparers for crafting compound licorice oral solutions. BGM also provides Qilian Shan oxytetracycline tablets, formulated to prevent and treat a range of ailments in poultry (chickens, turkeys), livesto ... ck (cattle, swine), and humans, in addition to Qilian Shan oxytetracycline APIs for use by pharmaceutical manufacturers. Beyond APIs, the company produces TCM derivatives such as Ahan antibacterial paste, which is designed for managing stubborn chronic skin conditions. Its diverse offerings also encompass heparin products, including heparin sodium preparations essential for pharmaceutical companies developing treatments for cardiovascular and cerebrovascular diseases, as well as hemodialysis applications. Furthermore, BGM supplies natural food products like Zhu Xiaochang sausage casings for culinary use. In the agricultural sector, it offers Xiongguan organic fertilizers, which enhance crop yields, improve soil chemical characteristics, and alleviate compaction, alongside Xiongguan organic-inorganic compound fertilizers engineered to promote superior plant development. Established in 2019, the company operated as Qilian International Holding Group Limited until adopting its current name, BGM Group Ltd, in October 2024.
Frequently Asked Questions
-
What is the current BGM Group Ltd. (BGM) stock price?
-
BGM Group Ltd.(NASDAQ:BGM) stock price is $0.3122 in the last trading session. During the trading session, BGM stock reached the peak price of $11.8 while $0.256 was the lowest point it dropped to. The percentage change in BGM stock occurred in the recent session was --7.66% while the dollar amount for the price change in BGM stock was -$-0.03.
-
BGM's industry and sector of operation?
-
The NASDAQ listed BGM is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of BGM?
-
Chen Xin | CEO, VP of Duxiaobao Management Committee & Chairman
Yuqing Li | Co-Chief Executive Officer
Zhao Huandi | Co-Chief Executive Officer & Director
Yaxuan Zhai | Chief Financial Officer
| -
How many employees does BGM have?
-
Number of BGM employees currently stands at 298. BGM operates from No. 152 Hongliang East 1st Street, Chengdu, SIC 610200, CN.
-
Link for BGM official website?
-
Official Website of BGM is: https://www.bgmgroupltd.com
-
How do I contact BGM?
-
BGM could be contacted at phone #86 28 6477 5180 and can also be accessed through its website. BGM operates from No. 152 Hongliang East 1st Street, Chengdu, SIC 610200, CN.
-
How many shares of BGM are traded daily?
-
The average number of BGM shares traded daily for last 3 months was 456.3K.
-
What is the market cap of BGM currently?
-
The market value of BGM currently stands at $62.63M with its latest stock price at $0.3122